According to our data in rats, peripheral 3.4-dihydroxyphenylalanine (DOPA) kinetics are similar to striatal DOPA and dopamine kinetics. The measurement of plasma l-3.4-dihydroxyphenylalanine (L-dopa) concentration is thus useful to predict dopamine kinetics in the striatum and to treat the motor fluctuations of parkinsonian patients. In patients with Parkinson’s disease (PD), long-term L-dopa therapy accelerated DOPA absorption and steepened features of L-dopa pharmacokinetics. In the senile-onset group, the pharmacokinetic pattern did not change even after long-term L-dopa therapy. The frequency of motor fluctuations is much lower in senile-onset patients with PD than in middle-onset patients. Differences in the pattern of L-dopa pharmacokinetics in the two groups may explain why the senile-onset group rarely develops ‘wearing-off’, even after long-term L-dopa therapy. L-dopa is transported by a saturable active transporter system, called the LNAA (large neutral amino acid) system, in the gut and blood brain barrier. L-dopa absorption is thus affected by food intake, especially a proteinrich diet. The slope of the time-concentration curve for L-dopa administered before a meal is steeper than if it is administered after a meal. Considering that pulsative stimulation of L-dopa may cause motor fluctuations, L-dopa should be given after meals whenever possible, even if it necessitates a higher L-dopa dose.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Poewe W, Wenning G (2002) Levodopa in Parkinson’s disease: mechanisms of action and pathophysiology of late failure. In: Jankovic J, Tolosa E (eds) Parkinson’s Disease and Movement Disorders. Lippincott Williams and Wilkins Philadelphia, PA, pp 104–115
Murata M, Kanazawa I (1993) Repeated L-dopa administration reduces the ability of dopamine storage and abolishes the supersensitivity of dopamine receptors in the striatum of intact rat. Neurosci Res 16:15–23
Murata M, Mizusawa H, Yamanouchi H, Kanazawa I (1996) Chronic levodopa therapy enhances dopa absorption: contribution to wearing-off. J Neural Transm 103:1177–1185
Murata M, Kanazawa I (1997) Effects of chronic levodopa therapy on dopa pharmacokinetics. Eur Neurol 38 (Suppl 2):50–55
Wade DN, Mearrick PT, Morris JL (1973) Active transport of L-dopa in the intestine. Nature 242:463–465
Fabbrini G, Juncos J, Mouradian MM, Serrati C, Chase TN (1987) Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson’s disease. Ann Neurol 21:370–376
Lyles GA, Callingham BA (1980) Shor- tand long-term effects of L-DOPA treatment upon monoamine oxidase: a comparative study in several rat tissues. Eur J Pharmacol 61:363–372
Abrams W, Coutinho CB, Leon AS, Spiegel HE (1971) Absorption and metabolism of levodopa. JAMA 218:1912–1914
Nutt JG, Fellman JH (1984) Pharmacokinetics of levodopa. Clin Neuropharmacol 7:35–49
Granerus AK, Jagenburg R, Svanborg A (1973) Intestinal decarboxylation of L-Dopa in relation to dose requirements in Parkinson’s disease. Naunyn Schmiedebergs Arch Pharmacol 280:429–439
Boomsma F, Meerwaldt JD, Man in’t Veld AJ, Hovestadt A, Schalekamp MA (1989) Induction of aromatic-L-amino acid decarboxylase by decarboxylase inhibitors in idiopathic parkinsonism. Ann Neurol 25:624–628
Murata M (2001) Dopa absorption in fluctuating Parkinson’s disease patients. In: Mizuno Y (ed) Neuroprotection and Neurodegeneration in Parkinson’s Disease. (Round Table Series). Royal Society of Medicine Press, London, pp 39–49
Mannisto PT, Kaakkola S (1990) Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson’s disease. Pharmacol Toxicol 66:317–323
About this article
Cite this article
Murata, M. Pharmacokinetics of L-dopa. J Neurol 253, iii47–iii52 (2006). https://doi.org/10.1007/s00415-006-3009-3
- Parkinson’s disease
- LNAA system